04:59 PM EST, 01/06/2025 (MT Newswires) -- Olema Pharmaceuticals ( OLMA ) late Monday disclosed plans for two prospective securities offerings, including up to $200 million of its common or preferred stock, warrants to buy shares or debt securities.

The company, which is developing cancer therapies for women, also plans potential sale of up to $150 million of its common stock through a sales agreement.

Olema said net proceeds from any future offering would be used for working capital, research and development expenses or other general corporate purposes.